Skip to main content
Figure 4 | BMC Infectious Diseases

Figure 4

From: Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries

Figure 4

Incidence of severe anaemia (including 95% confidence intervals) by ARV duration for all study arms (includes delivery related failures occurring at median t = 1.15 months following treatment initiation) ( P- value comparing incidence in <1 versus 1–1.9 month duration = 0.004).

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us